Connection
Thomas Flaig to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications Thomas Flaig has written about Receptors, Vascular Endothelial Growth Factor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.360 |
|
|
|
-
Li Y, Yang X, Su LJ, Flaig TW. VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells. Oncol Rep. 2010 Oct; 24(4):1019-28.
Score: 0.335
-
Berge EM, Bowles DW, Flaig TW, Lam ET, Jimeno A. Tivozanib: practical implications for renal cell carcinoma and other solid tumors. Drugs Today (Barc). 2013 May; 49(5):303-15.
Score: 0.025